Achieve Life Sciences (ACHV) Net Equity Issued and Repurchased (2012 - 2020)
Achieve Life Sciences (ACHV) posted Net Equity Issued and Repurchased of $9.0 million for Q4 2020, up 896800.0% on a QoQ basis from -$1000.0 in Q4 2018.
Achieve Life Sciences (ACHV) Net Equity Issued and Repurchased (2012 - 2020) Analysis & Trends
Achieve Life Sciences' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $9.0 million for Q4 2020.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $9.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $9.0 million (down 1.91% YoY) and the FY2021 annual result came in at $21.3 million, up 35.18% from the prior year.
- Net Equity Issued and Repurchased was $9.0 million for Q4 2020 at Achieve Life Sciences, up from -$1000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.0 million in Q4 2020 and bottomed at -$1.1 million in Q4 2017.
- A 3-year average of $1.8 million and a median of $175000.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 99.91% in 2018, while the deepest fall reached 99.91% in 2018.
- Achieve Life Sciences' Net Equity Issued and Repurchased stood at -$1.1 million in 2017, then surged by 99.91% to -$1000.0 in 2018, then soared by 896800.0% to $9.0 million in 2020.
- Business Quant data shows ACHV's Net Equity Issued and Repurchased at $9.0 million in Q4 2020, -$1000.0 in Q4 2018, and $175000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 8.97 Mn |
| Dec 31, 2020 | 8.97 Mn |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 1.11 Mn |
| Mar 31, 2018 | 1.11 Mn |
| Dec 31, 2017 | -1.07 Mn |
| Dec 31, 2017 | -1.07 Mn |
| Sep 30, 2015 | 14.42 Mn |
| Sep 30, 2015 | 14.42 Mn |
| Jun 30, 2015 | 213,000.00 |
| Jun 30, 2015 | 213,000.00 |
| Sep 30, 2014 | 19.51 Mn |
| Sep 30, 2014 | 19.51 Mn |
| Jun 30, 2014 | -11.22 Mn |
| Jun 30, 2014 | -11.22 Mn |
| Jun 30, 2012 | -23,000.00 |
| Jun 30, 2012 | -23,000.00 |